AstraZeneca's Weight-Loss Pill Shows Promising Results in Trials

AstraZeneca announced positive trial results for its new weight-loss pill, showing that patients lost an average of 10.5% of their body weight. This development positions the company to compete in the growing obesity treatment market.

8 Jun, 20:15 — 8 Jun, 20:15

Post Share

Sources

Showing 1 of 3 sources

FTVery High61d ago

AstraZeneca advances weight-loss pill to take aim at obesity leaders

Pill from drugmaker would put it into competition with market leaders Novo Nordisk and Eli Lilly

Read full article →

Coverage Timeline

First report: FT · 8 Jun, 20:15|Full coverage: 3 · 9h|Window: 9h

Left-leaningCenterRight-leaning

FT8 Jun, 20:15First to report

AstraZeneca advances weight-loss pill to take aim at obesity leaders

2h later

publico8 Jun, 22:15

Comprimido da AstraZeneca para a obesidade ajuda doentes a perder 10,5% do peso

7h later

dr-dk9 Jun, 05:19Latest update

PERSPECTA

PERSPECTA

AstraZeneca's Weight-Loss Pill Shows Promising Results in Trials

Sources

AstraZeneca advances weight-loss pill to take aim at obesity leaders

Coverage Timeline

AstraZeneca advances weight-loss pill to take aim at obesity leaders

Comprimido da AstraZeneca para a obesidade ajuda doentes a perder 10,5% do peso

AstraZeneca melder om nyt resultat for vægttabspille i forsøg

Related Stories

Wall Street Giant Bets Against Borr Drilling Stock

Heatwaves Impact Work Conditions and Productivity in Czech Republic

Understanding Market Terminology for Investors

Opel Astra Diesel Crowned Cheapest in Greece

PERSPECTA